CSPC Innovation(SZ:300765) Xin Lang Cai Jing·2025-09-17 02:25Company Overview - XinNuoWei is primarily engaged in the research, production, and sales of functional foods, with 88.93% of its revenue coming from this segment, followed by biopharmaceuticals at 8.91% and other sources at 2.16% [1][2] - The company was established on April 5, 2006, and went public on March 22, 2019 [1] Financial Performance - For the first half of 2025, XinNuoWei reported a revenue of 1.05 billion yuan, reflecting a year-on-year growth of 7.99%, while the net profit attributable to shareholders was a loss of 2.75 million yuan, a decrease of 102% compared to the previous year [2] - Since its A-share listing, XinNuoWei has distributed a total of 651 million yuan in dividends, with 500 million yuan distributed over the last three years [3] Stock Performance - As of September 17, XinNuoWei's stock price was 48.19 yuan per share, with a market capitalization of 67.69 billion yuan [1] - The stock has seen an increase of 81.37% year-to-date, but has experienced a decline of 13.95% over the last five trading days [1] - The company has appeared on the "Dragon and Tiger List" once this year, with a net buy of 39.71 million yuan on June 6 [1] Shareholder Structure - As of August 29, the number of shareholders for XinNuoWei was 15,400, a decrease of 8.22% from the previous period, with an average of 81,179 circulating shares per shareholder, an increase of 8.95% [2] - Major shareholders include Hong Kong Central Clearing Limited and various mutual funds, with notable changes in holdings among the top ten circulating shareholders [3]